4.7 Review

A common challenge in older adults: Classification, overlap, and therapy of depression and dementia

Journal

ALZHEIMERS & DEMENTIA
Volume 13, Issue 1, Pages 59-71

Publisher

WILEY
DOI: 10.1016/j.jalz.2016.08.007

Keywords

Depression; Dementia; Differential diagnosis; Classification; Prognosis; Biomarkers; Neuroimaging; Pharmacotherapy; Psychological intervention; Precision medicine

Funding

  1. AXA Research Fund
  2. Fondation Universite Pierre et Marie Curie
  3. Fondation pour la Recherche sur Alzheimer, Paris, France
  4. program Investissements d'avenir (Agence Nationale de la Recherche-10-1A Agence Institut Hospitalo-Universitaire-6) [ANR-10-IAIHU-06]
  5. UPMC Endowed Chair in Geriatric Psychiatry
  6. [P30 MH90333]

Ask authors/readers for more resources

Late-life depression is frequently associated with cognitive impairment. Depressive symptoms are often associated with or even precede a dementia syndrome. Moreover, depressive disorders increase the risk of persistence for mild cognitive impairment and dementia. Here, we present both the current state of evidence and future perspectives regarding the integration and value of clinical assessments, neuropsychological, neurochemical, and neuroimaging biomarkers for the etiological classification of the dementia versus the depression syndrome and for the prognosis of depression relating to dementia risk. Finally, we summarize the existing evidence for both pharmacotherapy and psychotherapy of depression in demented patients. There is an urgent need for large-scale collaborative research to elucidate the role and interplay of clinical and biological features in elderly individuals with depressive disorders who are at elevated risk for developing dementia. To overcome barriers for successful drug development, we propose the introduction of the precision medicine paradigm to this research field. (C) 2016 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available